no code implementations • 9 May 2024 • Siddharth Agarwal, David A. Wood, Mariusz Grzeda, Chandhini Suresh, Munaib Din, James Cole, Marc Modat, Thomas C Booth
Conclusion: The paucity of eligible studies reflects that most abnormality detection AI studies were not adequately validated in representative clinical cohorts.